Long-term follow-up of eosinophilic esophagitis in children and adults in Italy
Follows children and adults with eosinophilic esophagitis to see how the disease progresses.
Key facts
- Who runs it
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Where
- Italy2 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Natural History of Eosinophilic Esophagitis in Adult and Pediatric Population
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 1 Sept 2025
- Expected to end
- Dec 2027
- Type of study
- Observational, 2 groups
- Record updated
- 29 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and adults with a confirmed diagnosis of eosinophilic esophagitis (EoE). EoE is an allergy-linked swelling of the food pipe. The study follows how the disease and its treatment response change over time.
- Age
- 5 years and older
- Sex
- All sexes
- Disease stage
- An established diagnosis of eosinophilic esophagitis
Main reasons for not taking part
- Under 5 years old
- People who cannot read or write
- People who do not want to take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- patients with an established diagnosis of Eosinophilic esophagitis
- aged ≥5 years
- who gave written informed consent
Who cannot take part
- under 5 years old
- Patients who are illiterate
- Patients who are unwilling to participate
This trial is currently available in Italy.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Eosinophilic esophagitis (EoE) is a Th2-mediated disease induced by ingestion of ambiental and alimentary allergens. Incidence of EoE is increasing in recent years. Young male subjects are more often affected by EoE. Esophageal eosinophilic infiltrate causes different symptoms of esophageal dysfunction (i.e. dysphagia, food impaction, chest pain, heartburn). In pediatric population symptoms are nonspecific (failure to thrive, vomiting) and more common to be misdiagnosed.
Read full original descriptionShow less
Symptoms are commonly sporadic and underestimated by the patients. Therefore, specialistic evaluations are often delayed during the following months and years. Moreover, esophageal symptoms are often not investigated or associated with other diseases especially in pediatric population (i.e. gastroesophageal reflux disease). For this reason, diagnosis of EoE is often delayed. It is known from literature that diagnostic delay in EoE causes prolonged inflammation of the esophagus that may lead to esophageal fibrosis and stenosis with worsening of symptoms. Proton pump inhibitors (PPIs) and topical steroids are the first line medicines to induce EoE remission. Prolonged clinical remission is described in 60% of adult patients with PPIs. Recently orodispersible budesonide showed clinical remission after 1 year nearby in 90% of adult patients. Orodispersible budesonide is effective also in chidren with an efficacy in maintaining remission at lowest effective dosage after 60 weeks in around 78% of patients. Dysphagia Symptom Questionnaire (DSQ) is a validated tool used in order to measure clinical activity (dysphagia) in adult and pediatric patients with EoE. Italian version of the DSQ is not available in literature. Little is known in literature about the natural history of EoE patients, in particular about sustained clinical remission and appearance of complications (i.e. food impaction) during a prolonged follow-up period. Aim of our two-phase prospective study is to evaluate the clinical and endoscopic response at the current available therapies and the appearance of complications during a prolonged follow-up period in a cohort of adult and pediatric population.
The 2 groups in the trial
- Adult cohort
- Paediatric cohort
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Natural History of Eosinophilic Esophagitis in Adult and Pediatric Population: a Multicentric Prospective Study in Italy
- Plain-language title
- Long-term follow-up of eosinophilic esophagitis in children and adults in ItalyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 29 June 2026